Where do Revolution Medicines, Inc.'s ratios come from?

Every ratio is computed from Revolution Medicines, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	FY'25	FY'24	FY'23	FY'22
Returns
Return on equity	-202.1%-48.7pp	-153.4%+0.9pp	-154.3%-8.0pp	-146.3%-32.0pp
Return on assets	-164.9%-29.1pp	-135.8%-4.6pp	-131.2%-8.1pp	-123.2%-26.0pp
Return on invested capital	-247.5%-26.1pp	-221.4%+8.9pp	-230.3%-48.9pp	-181.4%-35.6pp
Efficiency
Asset turnover	0×0.0×	0×-0.1×	0.1×0.0×	0.2×-0.1×
Liquidity
Current ratio	40.4×-21.9×	62.3×+10.9×	51.4×+14.6×	36.8×-15.4×
Quick ratio	40.4×-21.9×	62.3×+10.9×	51.4×+14.6×	36.8×-15.4×
Cash ratio	6.5×-4.3×	10.8×-10.9×	21.7×+13.3×	8.4×-8.2×
Leverage
Debt-to-equity	0.3×+0.1×	0.2×0.0×	0.3×-0.2×	0.4×+0.2×
Debt-to-assets	0.2×+0.1×	0.2×0.0×	0.2×-0.1×	0.4×+0.1×
Per Share
Book value per share	$37.96-12.1%	$43.17+1.4%	$42.56+38.7%	$30.69-16.0%
Valuation
Market capitalization	$38.16B+39.4%	$27.37B+122%	$12.31B+65.7%	$7.43B-22.6%
Enterprise value	$37.41B+41.4%	$26.46B+147%	$10.73B+50.1%	$7.14B-20.4%
Price / book	22.1×+6.6×	15.4×+4.0×	11.4×-1.0×	12.4×-1.9×
Free cash flow yield	-33.4%-2.3pp	-31%+6.8pp	-37.9%+5.8pp	-43.7%-19.6pp
Earnings yield	-39.9%-7.7pp	-32.1%+10.9pp	-43.1%+7.1pp	-50.2%-22.0pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Revolution Medicines, Inc.'s ratios come from?: Every ratio is computed from Revolution Medicines, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.